Trial Profile
A Randomized, Controlled, Open-label Study of Comparing Immunogenicity of Sequential Hepatitis B and Hepatitis A Vaccination vs Vaccination with a Dual Hepatitis B and Hepatitis A Vaccine among HIV-1 infected Subjects (HepVac)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2015
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary) ; Hepatitis A vaccine inactivated; Hepatitis A-hepatitis B vaccine
- Indications Hepatitis A; Hepatitis B
- Focus Pharmacodynamics
- Acronyms HepVac
- 03 Aug 2011 New trial record